Viral Biosafety Level – 3
Indian Institute of Science
Bengaluru, India
------ FACILITY OVERVIEW
A dedicated facility for advanced viral research
The Viral Biosafety Level-3 (BSL-3) facility has been established in the Centre for Infectious Disease Research (CIDR) Building, IISc Campus, Bengaluru, for conducting research on BSL-3 category viral pathogens such as SARS-CoV-2.
The facility includes a BSL-3 laboratory for cell-based experiments and an infection-cum-necropsy room for animal experiments, along with appropriate change rooms, an autoclave room, and a plant room.
The laboratory incorporates specialized safety and engineering features to maintain the required negative-pressure environment and unidirectional airflow for laboratory personnel safety. Users should review the applicable SOPs and access requirements before requesting facility use.
Consultancy & Collaborative Research
The Viral BSL-3 facility undertakes consultancy research projects related to vaccine and antiviral studies.
Contact:
shashankt@iisc.ac.in
Standard Operating Procedures
Guidelines and Fee Structure
User Request Form
Medical Sheet for user
Viral BSL-3 Booking
------- INFRASTRUCTURE
Inside the Viral BSL-3 facility
Dedicated containment laboratories, controlled-access workspaces and specialized equipment support safe experimental workflows across cell based and animal studies.
------- RESEARCH PORTFOLIO
Vaccine Studies
CIDR’s Viral BSL-3 facility supports collaborative evaluation of vaccine candidates against SARS-CoV-2, including mRNA, glycoconjugate, virus-like particle, subunit and liposomal vaccine platforms.
Gennova Biopharmaceuticals Ltd., India
Glycovax Pharma, Canada
Premas Biotech Pvt. Ltd., India
CSIR-IMTECH, India
CSIR-CCMB, Hyderabad
Bhabha Atomic Research Centre, Mumbai
------- RESEARCH PORTFOLIO
Antiviral Studies
The facility also supports antiviral efficacy studies, cell-culture based testing, environmental decontamination evaluation and preclinical investigations.
CSIR-CIMAP, India
Sharp Business Systems, India
Kashiv Biosciences, USA
Biomoneta Research Pvt. Ltd., India
GeNext Genomics Pvt. Ltd.
------- CAPABILITIES
Services Provided
The facility supports a range of virology, immunology, histology and preclinical research workflows for academic and collaborative studies.
RT-PCR Related Assays
ELISA-Based Assays
Histology Studies
Neutralization Assays
Small-Animal Studies
Cytotoxicity & Antiviral Assays
------- Facility Contacts
Viral BSL-3 Laboratory
Faculty In-Charge
Dr. Shashank Tripathi
Viral Biosafety Level-3 Laboratory
Centre for Infectious Disease Research (CIDR)
MCB Department, Indian Institute of Science
shashankt@iisc.ac.in
In-Charge
Dr. Rohan Narayan
Viral Biosafety Level-3 Laboratory
Centre for Infectious Disease Research (CIDR)
MCB Department, Indian Institute of Science
